Literature DB >> 32772465

Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low-Risk Nuclear Studies in Pre-Liver Transplant Evaluation.

Adrián I Löffler1, Jorge A Gonzalez1,2, Shriram K Sundararaman1, Roshin C Mathew1, Patrick T Norton3, Klaus D Hagspiel3, Christopher M Kramer1,3, Michael Ragosta1, Campbell Rogers4, Neeral L Shah5, Michael Salerno1,3,6.   

Abstract

We investigated the presence and severity of coronary artery disease (CAD) in orthotopic liver transplantation (OLT) candidates using coronary artery calcium score (CACS) and coronary computed tomography angiography (CCTA) as compared with the prevalence of normal and abnormal single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). A total of 140 prospective OLT candidates without known CAD underwent coronary artery calcium (CAC) scans with (n = 77) or without CCTA and coronary computed tomography angiography-derived fractional flow reserve (FFRCT ; n = 57) using a dual-source computed tomography (CT) and were followed for 2.6 ± 1.4 years. Coronary plaque was quantified using the segment-involvement score (SIS) and segment stenosis score (SSS). The mean age was 59 ± 6 years, and 65.0% of patients were male. Mean Agatston CACS was 367 ± 653, and 15.0% of patients had CACSs of 0; 83.6% received a SPECT MPI, of which 95.7% were interpreted as normal/probably normal. By CCTA, 9.1% had obstructive CAD (≥70% stenosis), 67.5% had nonobstructive CAD, and 23.4% had no CAD. Nonobstructive CAD was diffuse with mean SIS 3.0 ± 2.9 and SSS 4.5 ± 5.4. Only 14 patients had high risk-findings (severe 3v CAD, n = 4, CACS >1000 n = 10) that prompted X-ray angiography in 3 patients who had undergone CCTA, resulting in revascularization of a high-risk obstruction in 1 patient who had a normal SPECT study. Patients with end-stage liver disease have a high prevalence of nonobstructive CAD by CCTA, which is undiagnosed by SPECT MPI, potentially underestimating cardiovascular risk. Deferring X-ray angiography unless high-risk CCTA findings are present is a potential strategy for avoiding unnecessary X-ray angiography.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32772465      PMCID: PMC9014709          DOI: 10.1002/lt.25869

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  31 in total

1.  Predictive value of stress myocardial perfusion imaging in liver transplant candidates.

Authors:  Charles J Davidson; Mihai Gheorghiade; James D Flaherty; Michael D Elliot; Srinivas P Reddy; Norman C Wang; Sri A Sundaram; Steven L Flamm; Andres T Blei; Michael I Abecassis; Robert O Bonow
Journal:  Am J Cardiol       Date:  2002-02-01       Impact factor: 2.778

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Robyn L McClelland; Hyoju Chung; Robert Detrano; Wendy Post; Richard A Kronmal
Journal:  Circulation       Date:  2005-12-19       Impact factor: 29.690

4.  Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation.

Authors:  V A Kryzhanovski; G A Beller
Journal:  Am J Cardiol       Date:  1997-04-01       Impact factor: 2.778

Review 5.  SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT.

Authors:  Sandra S Halliburton; Suhny Abbara; Marcus Y Chen; Ralph Gentry; Mahadevappa Mahesh; Gilbert L Raff; Leslee J Shaw; Jörg Hausleiter
Journal:  J Cardiovasc Comput Tomogr       Date:  2011 Jul-Aug

Review 6.  Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management.

Authors:  Javed Ehtisham; Mario Altieri; Ephrem Salamé; Eric Saloux; Isabelle Ollivier; Martial Hamon
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

7.  Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.

Authors:  Jihyun An; Ju Hyun Shim; Seon-Ok Kim; Danbi Lee; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

8.  SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee.

Authors:  Jonathon Leipsic; Suhny Abbara; Stephan Achenbach; Ricardo Cury; James P Earls; Gb John Mancini; Koen Nieman; Gianluca Pontone; Gilbert L Raff
Journal:  J Cardiovasc Comput Tomogr       Date:  2014-07-24

9.  Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.

Authors:  James K Min; Leslee J Shaw; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Donald J Russo; Nicholas J Lippolis; Daniel S Berman; Tracy Q Callister
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

10.  Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study.

Authors:  Michelle C Williams; Alastair J Moss; Marc Dweck; Philip D Adamson; Shirjel Alam; Amanda Hunter; Anoop S V Shah; Tania Pawade; Jonathan R Weir-McCall; Giles Roditi; Edwin J R van Beek; David E Newby; Edward D Nicol
Journal:  J Am Coll Cardiol       Date:  2019-01-29       Impact factor: 24.094

View more
  2 in total

Review 1.  Cardiac imaging for the assessment of patients being evaluated for liver transplantation.

Authors:  Kameel Kassab; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2021-04-06       Impact factor: 3.872

Review 2.  Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice.

Authors:  Maria Bonou; Sophie Mavrogeni; Chris J Kapelios; Marina Skouloudi; Constantina Aggeli; Evangelos Cholongitas; George Papatheodoridis; John Barbetseas
Journal:  Diagnostics (Basel)       Date:  2021-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.